Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
0.458
-0.012 (-2.55%)
Dec 5, 2025, 4:00 PM EST - Market closed
Impact BioMedical Revenue
Impact BioMedical had revenue of $18.00K in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $25.00K.
Revenue (ttm)
$25.00K
Revenue Growth
n/a
P/S Ratio
225.42
Revenue / Employee
$12,500
Employees
2
Market Cap
47.92M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
IBO News
- 3 months ago - Impact Biomedical Inc (IBO) Announces 3F™ US Patent Issue - GlobeNewsWire
- 5 months ago - Dr Ashleys Limited and Impact BioMedical Inc. Announce Strategic Merger - GlobeNewsWire
- 9 months ago - Impact Biomedical Inc. Announcement Stock Activity/Pricing - GlobeNewsWire
- 11 months ago - Impact BioMedical Inc. to Present at The Microcap Conference - GlobeNewsWire
- 1 year ago - Impact BioMedical Inc. Announces Issuance of Canadian Patent for Linebacker™ Technology Targeting Inflammatory Disease - GlobeNewsWire
- 1 year ago - Impact BioMedical Inc. (NYSE American: IBO) Announces IPO Participation with Strong Support from Partners and Affiliates - GlobeNewsWire
- 1 year ago - Impact BioMedical Inc. (NYSE: IBO) Announces 3F™ US Patent Issue - GlobeNewsWire
- 1 year ago - Impact BioMedical Inc. Announces the Closing of its Initial Public Offering - GlobeNewsWire